INSURASALES

Analyst Maintains Buy Rating on Globe Life with $118 Price Target

Analyst John Barnidge affirms a Buy rating on Globe Life, targeting $118. Explore the latest insights and ratings for GL stock.

Navigating Medicare's Initial Enrollment Period: Essential Steps for New Recipients

Learn about Medicare's initial enrollment period, how it affects new enrollees like Jenny turning 65, and the necessary steps to take for smooth enrollment without penalties.

Aetna Announces 2025 Medicare Product Offerings with $0 Premium Plans

Aetna unveils its comprehensive 2025 Medicare product offerings, featuring $0 premium plans, diverse options for Medicare beneficiaries, and a commitment to quality healthcare services.

Understanding Medicare: Advantages of Supplement Plans Over PPOs

Explore the important differences between Medicare Advantage and Medicare Supplement plans to ensure informed healthcare decisions. Case study of a reader's experience warns of misconceptions about coverage and costs.

BCBSIL to Acquire Cigna Healthcare’s Medicare Advantage Business

Blue Cross and Blue Shield of Illinois announces plans to acquire Cigna Healthcare’s Medicare Advantage and related businesses, enhancing service quality and provider support.

Essence Healthcare Launches Medicare Advantage Plans in Chicago

Essence Healthcare expands to Chicago, offering Medicare Advantage plans focused on quality and access for beneficiaries. Explore patient-centered services starting this fall.

Humana Faces Star Rating Drop Affecting Medicare Advantage Revenue

Humana reports a significant drop in Medicare Advantage Star Ratings for 2025, impacting future revenues and leading to plan exits in several counties.

Ambetter Offers Affordable Health Plans for Washington Residents in 2025

Ambetter from Coordinated Care will provide a variety of affordable health insurance plans for residents in Washington during the 2025 open enrollment period.

Medicare Advantage Overpayments: CMS Criticized for Inaction

The CMS faces criticism for failing to address billions in Medicare Advantage overpayments. Investigate how political influence impacts oversight and what this means for seniors.